Eric L. Wallace

Eric Wallace practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Eric Wallace's NPI, 1871706960, was assigned on May 7, 2007. Eric Wallace graduated from University of Alabama School of Medicine in 2006. Eric Wallace holds Alabama license 28356.

Eric Wallace's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Eric Wallace's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Eric Wallace is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Eric Wallace practices. Vendor and product names are available with a free account.

Nephrology is Eric Wallace's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Eric Wallace is licensed in Alabama.

CMS data shows 218 Medicare services from Eric Wallace across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $46,610 for them.

CMS counts 55 Medicare patients who saw Eric Wallace in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 5.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eric Wallace's median patient age at 50, with 57% women.

In 2024, Eric Wallace wrote 541 Medicare Part D claims for 69 patients. 84% of them were for generic drugs. CMS names the drug for 346 of them, across 16 drugs with 11 or more claims each, at $516,879 in total drug cost. In 2023, CMS named 465 claims across 18 drugs.

Eric Wallace accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 62 papers to Eric Wallace, published from 2010 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Peritoneal Dialysis, Telemedicine and Fabry Disease. Eric Wallace has published most often in Am J Kidney Dis. Eric Wallace's most frequent co-authors are David G. Warnock, MD, Waldemar Alberto Carlo, MD and Daniel I-Hsin Chu, MD.

Dmand AI links Eric Wallace to 4 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Fabry Disease, Cerebral Small Vessel Diseases and Kidney Failure, Chronic. Protalix sponsors the most, 2.

CMS Open Payments shows 175 general payments to Eric Wallace from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Sanofi and Genzyme US Companies paid the most, $119,609. It also lists 1 research payment totaling $300 in 2019.

Eric Wallace graduated from University of Alabama School of Medicine in 2006.